Related Experiment Video
Updated: Jan 1, 2026

06:10
An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis
Published on: August 6, 2020
6.2K
Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction
Natalie Jia Ying Yeo1, Ebenezer Jia Jun Chan2,3, Christine Cheung1,4
1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Frontiers in Pharmacology
|December 19, 2019
Summary
This review explores vascular issues in age-related macular degeneration (AMD), focusing on endothelial dysfunction and VEGF-independent pathways. It highlights new research directions for improving ocular vascular function and vision.
Area of Science:
- Ophthalmology
- Cardiovascular Biology
- Genetics
Background:
- Vascular pathology underlies many systemic and ocular diseases, including age-related macular degeneration (AMD).
- AMD involves abnormal blood vessel growth (choroidal neovascularization) in the eye, leading to vision loss.
- Endothelial dysfunction, an early vascular event, is often overlooked in AMD research.
Purpose of the Study:
- To review the vascular underpinnings of AMD.
- To explore genetic and systemic factors influencing AMD.
- To discuss experimental models and novel therapeutic pathways for AMD.
Main Methods:
- Literature review of vascular pathology in AMD.
- Analysis of endothelial-centric and non-cell autonomous mechanisms.
- Examination of VEGF-independent pathways.
Main Results:
- Current anti-VEGF therapies for AMD have limitations, including partial efficacy and patient refractoriness.
- VEGF-independent mechanisms are crucial for understanding AMD progression.
- Early vascular events like endothelial dysfunction warrant further investigation.
Conclusions:
- Understanding vascular regulation is key to treating AMD and other eye disorders.
- Exploring novel, VEGF-independent pathways may lead to improved AMD treatments.
- Future research should focus on enhancing ocular vascular function for better visual outcomes.
Related Concept Videos
Mechanism of Angiogenesis
6.5K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.5K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Coronary Artery Disease II: Pathophysiology
314
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
314

